GlassScriptPhysician profile
Brian Jacob Buhrer
NPI 1649931924
$7,598.12
in general payments reported to CMS, 2019-2025
42 companies · $2,725 in 2025
The $2,725 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,474 · 2023: $1,335 · 2024: $2,064 · 2025: $2,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,943 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,942.73 |
| Education | $181.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,924.65 | 2022-2025 | Erleada, Carvykti, Rybrevant |
| Teleflex LLC | $714.93 | 2022-2025 | Barrigel, Urolift |
| Abbvie INC. | $518.68 | 2022-2025 | |
| Procept Biorobotics Corporation | $504.56 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Pfizer INC. | $330.55 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $329.08 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $321.67 | 2022-2024 | Prolaris, Myrisk |
| Olympus America INC. | $315.44 | 2024-2025 | Itind System |
| Astrazeneca Pharmaceuticals LP | $303.23 | 2022-2025 | Lynparza, Imfinzi |
| Novartis Pharmaceuticals Corporation | $275.21 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $237.15 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $231.66 | 2022-2025 | Provenge |
| Astellas Pharma US INC | $204.55 | 2024-2025 | Xtandi, Veozah |
| Endo USA, INC. | $121.82 | 2025 | Xiaflex |
| Urogen Pharma, INC. | $108.42 | 2024-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $107.57 | 2022-2025 | Lynparza, Welireg |
| Antares Pharma, INC. | $86.33 | 2022-2025 | Xyosted |
| Halozyme INC | $85.00 | 2023 | |
| Innovation Technologies INC | $68.27 | 2024 | Irrisept |
| Agiliti Surgical, INC. | $67.81 | 2025 | Quanta System Fiber Dust Tfl Laser, Olympus Soltive Tfl Laser, Koelis Trinity Mri/US Fusion |
| Telix Pharmaceuticals | $58.93 | 2024 | Illuccix |
| Inspire Medical Systems, INC. | $56.74 | 2023 | Inspire |
| Boston Scientific Corporation | $53.99 | 2022-2025 | Ams 800 Artificial Urinary Sphincter, Spaceoar Vue System - 10ml |
| Amgen INC. | $44.00 | 2022-2023 | Prolia |
| Endo Pharmaceuticals INC. | $43.03 | 2022 | |
| Palette Life Sciences, INC. | $42.42 | 2022 | |
| Ferring Pharmaceuticals INC. | $41.64 | 2025 | Adstiladrin |
| Myovant Sciences INC. | $38.40 | 2022 | |
| Progenics Pharmaceuticals, INC. | $36.03 | 2022-2025 | |
| Millicent US INC | $32.98 | 2024 | Intrarosa |
| Clinical Laserthermia Systems Americas INC. | $32.93 | 2023 | Mobile Laser Unit |
| Angiodynamics, INC. | $32.52 | 2025 | Nanoknife |
| Kowa Pharmaceuticals America, INC. | $30.82 | 2022-2023 | Seglentis |
| Coloplast Corp | $30.22 | 2025 | |
| Novo Nordisk INC | $24.45 | 2024 | Rivfloza |
| Tolmar, INC. | $22.78 | 2023 | |
| Hollister Incorporated | $22.60 | 2022 | |
| 180 Medical, INC. | $22.29 | 2022 | |
| Caris Mpi, INC. | $22.16 | 2025 | Mi Cancer Seek |
| Urovant Sciences INC | $20.81 | 2022 | |
| Abc Home Medical Supply, INC. | $18.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Buhrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.